Mindray TD60 Transmitter Battery Charger Recall: Swollen Battery Case Risk
Mindray recalls TD60 Transmitter battery chargers (part 115-030108-00) due to risk of battery swelling and separation. Affected units may need replacement.
Use caution until it’s fixed
A damaged circuit board in the battery charger can cause the battery to overcharge and the battery case to swell and separate.
Contact the company
What happened, in plain English
Mindray is recalling TD60 Transmitter battery chargers that can cause the battery to overcharge, swell, and separate. This poses a risk of injury from the battery case separating. Read more at govinfonow.com/recall/73425-mindray-td60-transmitter-battery-charger-recall-swollen-battery-case-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/73425-mindray-td60-transmitter-battery-charger-recall-swollen-battery-case-risk · Updated September 20, 2026 · FDA enforcement record: FDA #Z-0554-2018
Cite this page
“Mindray TD60 Transmitter Battery Charger Recall: Swollen Battery Case Risk.” GovInfoNow, updated September 20, 2026. https://govinfonow.com/recall/73425-mindray-td60-transmitter-battery-charger-recall-swollen-battery-case-risk. Based on FDA recall #Z-0554-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0554-2018%22&limit=1).
Why it’s dangerous
A damaged circuit board in the charger can cause overcharging, leading to battery swelling and separation. This could result in injury if the battery case breaks apart.
Who’s affected
Healthcare professionals using the BeneVision Central Station system with this battery charger are most at risk. Patients using the device may also be affected if the battery separates.
How to tell if you have this one
Check for part number 115-030108-00 on the battery charger. The charger is used with the BeneVision Central Station system.
- Brand
Mindray- Category
Medical device
What to do — step by step
Check Battery Condition
Inspect the battery charger for swelling or separation of the battery case.
Contact Manufacturer
Reach out to Mindray North America for replacement or repair options.
Where it went and when
Where it was distributed
Distributed in 26 states and Puerto Rico.
FDA distribution: “Distributed in 26 states: AL, CA, CO, FL, GA, IA, IN, ME, MI, MN, MO, NC, ND, NE, NH, NJ, NM, NV, NY, OH, PA, SD, TX, UT, WA, and WY; and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, California, Colorado, Florida, Georgia, Indiana, Iowa, Maine, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Pennsylvania, Puerto Rico, South Dakota, Texas, Utah, Washington, Wyoming.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0554-2018 (July 14, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0554-2018 to see it in context.
- Plain-language summary written by qwen3:4b on September 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.